Biodegradable-polymer infinnium paclitaxel-eluting and supralimus sirolimus-eluting stents reduce repeat intervention in complex cases: findings from the 3-arm PAINT randomized controlled trial

被引：0
|
作者：
Lemos, P. A. [1 ]
Moulin, B. [2 ]
Perin, M. A. [3 ]
Oliveira, L. A. R. R. [4 ]
Arruda, J. A. [5 ]
Lima, V. C. [6 ]
Lima, A. A. G. [7 ]
Caramori, P. R. A. [8 ]
Medeiros, C. R. [9 ]
Barbosa, M. R. [10 ]
机构：
[1] Univ Sao Paulo, Heart Inst Incor, Catheterizat Lab, BR-09500900 Sao Paulo, Brazil
[2] HU Cassiano Antonio de Moraes, Vitoria, Brazil
[3] Hosp Santa Marcelina, Sao Paulo, Brazil
[4] Natal Hosp Ctr, Natal, RN, Brazil
[5] Hosp Merid, Vitoria, Brazil
[6] Fed Univ Sao Paulo UNIFESP EPM, Hosp Rim & Hipertensao, Sao Paulo, Brazil
[7] Hosp Univ Walter Cantidio, Fortaleza, Ceara, Brazil
[8] Hosp Sao Lucas PUC RS, Cardiovasc Res Ctr, Porto Alegre, RS, Brazil
[9] Rede DOr Hosp, Rio De Janeiro, Brazil
[10] Hosp Biocor, Belo Horizonte, MG, Brazil
来源：
EUROPEAN HEART JOURNAL | 2008年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：676 / 676
页数：1
相关论文
共 33 条
  • [1] Biodegradable-polymer Infinnium Paclitaxel-eluting And Supralimus Sirolimus-eluting Stents Reduce Neointimal Proliferation In Patients At Low Risk Of Restenosis: Findings From The 3-arm Paint Randomized Controlled Trial
    Lemos, Pedro A.
    Moulin, Bruno
    Perin, Marco A.
    de Oliveira, Ludmilla A.
    Airton de Arruda, J.
    de Lima, Valter C.
    Lima, Antonio A.
    Lasevitch, Ricardo
    Medeiros, Cesar R.
    Barbosa, Mauriclo R.
    de Brito, Fabio S., Jr.
    Ribeiro, Expedite E.
    Caramori, Paulo R.
    CIRCULATION, 2008, 118 (18) : S1043 - S1044
  • [2] Paclitaxel-eluting stents versus sirolimus-eluting stents in patients with diabetes mellitus undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
    Wang, Hui-bo
    Zeng, Ping
    Yang, Jun
    Yang, Jian
    Liu, Xiao-wen
    INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (07) : 1005 - 1013
  • [3] Efficacy and safety of a biodegradable polymer sirolimus-eluting stent in primary percutaneous coronary intervention: a randomized controlled trial
    Li, Qiang
    Tong, Zichuan
    Wang, Lefeng
    Zhang, Jianjun
    Ge, Yonggui
    Wang, Hongshi
    Li, Weiming
    Xu, Li
    Ni, Zhuhua
    Yang, Xinchun
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (06) : 1040 - 1048
  • [4] Paclitaxel-eluting stents versus sirolimus-eluting stents in patients with diabetes mellitus undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
    Hui-bo Wang
    Ping Zeng
    Jun Yang
    Jian Yang
    Xiao-wen Liu
    Internal and Emergency Medicine, 2016, 11 : 1005 - 1013
  • [5] Open-labeled randomized controlled trial to evaluate the 1-year clinical outcomes of polymer-free sirolimus-eluting coronary stents as compared with biodegradable polymer-based sirolimus-eluting coronary stents
    Viswanathan, Sunitha
    Gopinath, Kiran
    Koshy, George
    Gupta, Prabha Nini
    Velappan, Praveen
    INDIAN HEART JOURNAL, 2018, 70 : S323 - S328
  • [6] Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial
    Han, Jung-Kyu
    Yang, Seokhun
    Hwang, Doyeon
    Park, Sang-Hyeon
    Kang, Jeehoon
    Yang, Han-Mo
    Park, Kyung Woo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Cho, Jin-Man
    Cho, Janghyun
    Bang, Duk Won
    Lee, Jae-Hwan
    Lee, Han Cheol
    Kim, Kyung-Jin
    Chun, Woo Jung
    Seo, Won-Woo
    Park, Woo-Jung
    Park, Sang Min
    Kim, Jin Won
    Kim, Hyo-Soo
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (07) : e013585
  • [7] Ultrathin-Strut Biodegradable-Polymer Sirolimus-Eluting Stents Versus Thin-Strut Durable-Polymer Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Individual Patient Data From Randomized Controlled Trials
    Pilgrim, Thomas
    Rothenbuhler, Martina
    Siontis, George C. M.
    Kandzari, David E.
    Asami, Masahiko
    Lefevre, Thierry
    Piccolo, Raffaele
    Hunziker, Lukas
    Koolen, Jacques
    Saito, Shigeru
    Slagboom, Ton
    Waksman, Ron
    Windecker, Stephan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (04) : S19 - S20
  • [8] Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease 3-Year Outcomes From a Randomized Clinical Trial
    Byrne, Robert A.
    Kastrati, Adnan
    Massberg, Steffen
    Wieczorek, Anna
    Laugwitz, Karl-Ludwig
    Hadamitzky, Martin
    Schulz, Stefanie
    Pache, Juergen
    Fusaro, Massimiliano
    Hausleiter, Joerg
    Schoemig, Albert
    Mehilli, Julinda
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (13) : 1325 - 1331
  • [9] Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials
    Pilgrim, Thomas
    Rothenbuhler, Martina
    Siontis, George C. M.
    Kandzari, David E.
    Iglesias, Juan F.
    Asami, Masahiko
    Lefevre, Thierry
    Piccolo, Raffaele
    Koolen, Jacques
    Saito, Shigeru
    Slagboom, Ton
    Muller, Olivier
    Waksman, Ron
    Windecker, Stephan
    AMERICAN HEART JOURNAL, 2021, 235 : 140 - 148
  • [10] PAINTPercutaneous Intervention with a Biodegradable, Polymer-Based Paclitaxel-Eluting, Sirolimus-Eluting or Bare Stents for the Treatment of De Novo Coronary Lesions — Randomisierte Studie zum Vergleich von Sirolimus und Paclitaxel freisetzenden Stents, basierend auf einem biodegradierbarem Polymer, mit unbeschichteten Stents zur Behandlung der stenosierenden koronaren Herzerkrankung
    Herz Kardiovaskuläre Erkrankungen, 2008, 33 (5) : 385 - 385
1234